Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VIP: Validation of the Italian Version of the Patient-Reported Outcomes - Common Terminology Criteria for Adverse Events (PRO-CTCAE): A Prospective Multicenter Observational Study on Different Cancer Types

NCT04416672 is registered in ClinicalTrials.gov with National Cancer Institute, Naples as lead sponsor.

NCT NCT04416672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04416672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VIP: Validation of the Italian Version of the Patient-Reported Outcomes - Common Terminology Criteria for Adverse Events (PRO-CTCAE): A Prospective Multicenter Observational Study on Different Cancer Types
Lead sponsor
National Cancer Institute, Naples
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2018
Completion date
July 31, 2024
Enrollment
3,675 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

malignant neoplasms